KE108-conjugated unimolecular micelles loaded with a novel HDAC inhibitor thailandepsin-A for targeted neuroendocrine cancer therapy
- 1 August 2016
- journal article
- Published by Elsevier in Biomaterials
- Vol. 97, 22-33
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01 CA121115, 1K25CA166178, R21CA196653)
- American Cancer Society (120319–RPM–11–080–01–TBG, TBE–121413)
- Caring for Carcinoids Foundation
- AACR
This publication has 54 references indexed in Scilit:
- Facile preparation of heparin/CaCO3/CaP hybrid nano-carriers with controllable size for anticancer drug deliveryColloids and Surfaces B: Biointerfaces, 2013
- Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imagingBiomaterials, 2012
- Nuclear-Targeted Drug Delivery of TAT Peptide-Conjugated Monodisperse Mesoporous Silica NanoparticlesJournal of the American Chemical Society, 2012
- Expression of the Active Notch1 Decreases MTC Tumor Growth In VivoJournal of Surgical Research, 2011
- Thailandepsins: Bacterial Products with Potent Histone Deacetylase Inhibitory Activities and Broad-Spectrum Antiproliferative ActivitiesJournal of Natural Products, 2011
- Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphomaThe Journal of Antibiotics, 2011
- Carcinoid TumorsThe Oncologist, 2008
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticlesProceedings of the National Academy of Sciences, 2008
- Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug DeliveryACS Nano, 2008
- Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)Blood, 2006